Intermittent catheterisation after botulinum toxin injections: the time to reassess our practice

Intermittent catheterisation after botulinum toxin injections: the time to reassess our practice Int Urogynecol J (2017) 28:1351–1356 DOI 10.1007/s00192-017-3271-1 ORIGINAL ARTICLE Intermittent catheterisation after botulinum toxin injections: the time to reassess our practice 1,2 3 4 Linda Collins & Sanchutha Sathiananthamoorthy & Mandy Fader & James Malone-Lee Received: 7 November 2016 /Accepted: 5 January 2017 /Published online: 23 January 2017 The International Urogynecological Association 2017 Abstract CISC prior to injections and continued. None of the 196 pa- Introduction and hypothesis Botulinum toxin has become a tients developed acute retention or significant voiding widely adopted treatment for patients with recalcitrant over- symptoms. active bladder (OAB) symptoms. Some recommend clean in- Conclusions Our study indicates that routine administration termittent self-catheterisation (CISC) if a postvoid residual of CISC based on an arbitrary PVR volume is unlikely to (PVR) >200 ml posttreatment, but there is no evidence for this confer benefit. In order to avoid patients being deterred from recommendation. The aim of this study was to identify wheth- botulinum treatment, we recommend that CISC be reserved er abstinence from CISC as a routine strategy for patients with for those who have troublesome voiding symptoms as well as a PVR following intradetrusor botulinum toxin injections is a raised PVR. It is unlikely that CISC, initiated http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Urogynecology Journal Springer Journals

Intermittent catheterisation after botulinum toxin injections: the time to reassess our practice

Loading next page...
 
/lp/springer_journal/intermittent-catheterisation-after-botulinum-toxin-injections-the-time-4jGRD1048D
Publisher
Springer London
Copyright
Copyright © 2017 by The International Urogynecological Association
Subject
Medicine & Public Health; Gynecology; Urology
ISSN
0937-3462
eISSN
1433-3023
D.O.I.
10.1007/s00192-017-3271-1
Publisher site
See Article on Publisher Site

Abstract

Int Urogynecol J (2017) 28:1351–1356 DOI 10.1007/s00192-017-3271-1 ORIGINAL ARTICLE Intermittent catheterisation after botulinum toxin injections: the time to reassess our practice 1,2 3 4 Linda Collins & Sanchutha Sathiananthamoorthy & Mandy Fader & James Malone-Lee Received: 7 November 2016 /Accepted: 5 January 2017 /Published online: 23 January 2017 The International Urogynecological Association 2017 Abstract CISC prior to injections and continued. None of the 196 pa- Introduction and hypothesis Botulinum toxin has become a tients developed acute retention or significant voiding widely adopted treatment for patients with recalcitrant over- symptoms. active bladder (OAB) symptoms. Some recommend clean in- Conclusions Our study indicates that routine administration termittent self-catheterisation (CISC) if a postvoid residual of CISC based on an arbitrary PVR volume is unlikely to (PVR) >200 ml posttreatment, but there is no evidence for this confer benefit. In order to avoid patients being deterred from recommendation. The aim of this study was to identify wheth- botulinum treatment, we recommend that CISC be reserved er abstinence from CISC as a routine strategy for patients with for those who have troublesome voiding symptoms as well as a PVR following intradetrusor botulinum toxin injections is a raised PVR. It is unlikely that CISC, initiated

Journal

International Urogynecology JournalSpringer Journals

Published: Jan 23, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off